ProfileGDS4718 / 217389_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 75% 76% 72% 76% 75% 67% 68% 78% 76% 77% 73% 75% 71% 68% 67% 73% 74% 71% 68% 80% 77% 72% 74% 75% 72% 68% 75% 68% 72% 73% 69% 67% 79% 75% 68% 68% 70% 74% 76% 66% 75% 72% 66% 66% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.3233875
GSM549102patient 115, normal, homogenized [OPG study]7.3745176
GSM549104patient 119, normal, homogenized [OPG study]7.0577172
GSM549108patient 138, normal, homogenized [OPG study]7.3389276
GSM549119patient 077, normal, homogenized [OPG study]7.2456275
GSM549133patient 032, cancer, homogenized [OPG study]6.6971667
GSM549139patient 042, cancer, homogenized [OPG study]6.6910768
GSM549099patient 107, normal, homogenized [OPG study]7.5934578
GSM549109patient 139, normal, homogenized [OPG study]7.3699176
GSM549110patient 046, normal, homogenized [OPG study]7.4965877
GSM549114patient 063, normal, homogenized [OPG study]7.135573
GSM549122patient 082, normal, homogenized [OPG study]7.307375
GSM549134patient 033, cancer, homogenized [OPG study]6.9439771
GSM549136patient 036, cancer, homogenized [OPG study]6.7553168
GSM549140patient 044, cancer, homogenized [OPG study]6.6716167
GSM549111patient 047, normal, homogenized [OPG study]7.1720173
GSM549113patient 057, normal, homogenized [OPG study]7.2411474
GSM549132patient 031, cancer, homogenized [OPG study]6.9795371
GSM549137patient 038, cancer, homogenized [OPG study]6.6906868
GSM549142patient 047, cancer, homogenized [OPG study]7.6006280
GSM549100patient 110, normal, homogenized [OPG study]7.4427477
GSM549107patient 135, normal, homogenized [OPG study]7.0453772
GSM549115patient 068, normal, homogenized [OPG study]7.3214974
GSM549116patient 072, normal, homogenized [OPG study]7.3674375
GSM549120patient 078, normal, homogenized [OPG study]7.0104172
GSM549131patient 030, cancer, homogenized [OPG study]6.7538568
GSM549118patient 074, normal, homogenized [OPG study]7.3369375
GSM549129patient 027, cancer, homogenized [OPG study]6.7889268
GSM549123patient 088, normal, homogenized [OPG study]7.0697772
GSM549124patient 006, cancer, homogenized [OPG study]7.0585173
GSM549126patient 015, cancer, homogenized [OPG study]6.8095669
GSM549128patient 025, cancer, homogenized [OPG study]6.6570867
GSM549103patient 117, normal, homogenized [OPG study]7.6224579
GSM549117patient 073, normal, homogenized [OPG study]7.2958575
GSM549138patient 041, cancer, homogenized [OPG study]6.7579468
GSM549141patient 045, cancer, homogenized [OPG study]6.7719868
GSM549130patient 028, cancer, homogenized [OPG study]6.8372170
GSM549101patient 111, normal, homogenized [OPG study]7.1840874
GSM549105patient 128, normal, homogenized [OPG study]7.3634876
GSM549106patient 134, normal, homogenized [OPG study]6.6171466
GSM549112patient 048, normal, homogenized [OPG study]7.3035575
GSM549125patient 011, cancer, homogenized [OPG study]7.016272
GSM549127patient 024, cancer, homogenized [OPG study]6.640166
GSM549135patient 035, cancer, homogenized [OPG study]6.5919666